4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-20-046134
SVP, Finance and CFO sold 22,554 shares at $48.00 ($1,082,592)
- SVP, Finance and CFO acquired 29,804 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cotroneo Pat · SVP, Finance and CFO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-08-07 | Exercise or conversion : show line 1 in the form | +22,554 | $19.39 | $437,322 | 293,614 | D |
| 2020-08-07 | Sale : show line 2 in the form | −22,554 | $48.00 | $1,082,592 | 271,060 | D |
| 2020-08-11 | Exercise or conversion : show line 3 in the form | +3,750 | $19.39 | $72,713 | 274,810 | D |
| 2020-08-11 | Exercise or conversion : show line 4 in the form | +3,500 | $18.00 | $63,000 | 278,310 | D |
| Open-market sales · 22,554 sh · avg $48.00 · $1,082,592 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-08-07 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −22,554 | $19.39 | 2026-02-22 | 22,554 | 9,446 | D |
| 2020-08-11 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −3,750 | $19.39 | 2026-02-22 | 3,750 | 5,696 | D |
| 2020-08-11 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −3,500 | $18.00 | 2024-11-13 | 3,500 | 0 | D |
Loading xslF345X03/doc4.xml…